Wangang Gu, Ph.D.
Affiliations: | 2011 | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
Molecular BiologyGoogle:
"Wangang Gu"Parents
Sign in to add mentor| David C. Cheong Wan | grad student | 2011 | Chinese University of Hong Kong | |
| (Characterization of HIV-1 Integrase Nuclear Translocation and Chemokine Receptor Internalization for Development of New Class of Anti-AIDS Drugs.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gu WG. (2015) Genome editing-based HIV therapies. Trends in Biotechnology. 33: 172-9 |
| Gu WG, Liu BN, Yuan JF. (2015) Virtual-screening targeting Human Immunodeficiency Virus type 1 integrase-lens epithelium-derived growth factor/p75 interaction for drug development. Journal of Drug Targeting. 23: 134-9 |
| Gu WG. (2014) Newly approved integrase inhibitors for clinical treatment of AIDS. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 68: 917-21 |
| Gu WG, Zhang X, Yuan JF. (2014) Anti-HIV drug development through computational methods. The Aaps Journal. 16: 674-80 |
| Zhang X, Huang SZ, Gu WG, et al. (2014) Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation. Chinese Journal of Natural Medicines. 12: 186-93 |
| Gu WG, Ip DT, Liu SJ, et al. (2014) 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor. Chemico-Biological Interactions. 213: 21-7 |